Skip to main content
Top
Published in: Clinical and Experimental Medicine 4/2020

01-11-2020 | Systemic Lupus Erythematosus | Original Article

Association between complement 4 copy number variation and systemic lupus erythematosus: a meta-analysis

Authors: Ziyan Wu, Shulan Zhang, Ping Li, Fengchun Zhang, Yongzhe Li

Published in: Clinical and Experimental Medicine | Issue 4/2020

Login to get access

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by multiple genetic mutations. Complement 4 (C4) copy number variation (CNV) is a target-of-interest located on chromosome 6. C4 encodes for either of the two C4 paralogs, C4A or C4B, and low C4 levels have been associated with SLE activity. In this study, we conducted a meta-analysis to comprehensively understand the role of C4 CNV in SLE. Three databases (PubMed, Embase, and Web of Science) were searched for relevant studies. Two investigators independently extracted and evaluated data from eligible studies. Associations between C4 CNV and SLE were estimated by odds ratios (OR) and 95% confidence intervals (95% CI). Further analysis was conducted using the STATA 12.0 software. A total of eight case-control studies were included in the analysis with 4107 SLE patients and 5889 healthy controls. Six studies used TaqMan real-time PCR to genotype C4 CNV, with 1 study used paralog ratio test and other one used multiplex ligation-dependent probe amplification (MLPA). Lower total C4 CNV and C4A CNV were associated with SLE in the overall analysis (pooled OR: 1.55, 95% CI: 1.23–1.95; pooled OR: 1.86, 95% CI: 1.51–2.29). The subgroup analysis found that total C4 CNV and lower C4A CNV were significantly associated with SLE in Caucasians (pooled OR: 1.84, 95% CI: 1.60–2.12; pooled OR: 2.23, 95% CI:1.92–2.59). However, the association was not detected in East Asians. Lastly, SLE was not associated with C4B CNV, long C4 CNV, or short C4 CNV. The meta-analysis confirmed that lower total C4 CNV and lower C4A CNV are associated with SLE in certain populations. Future studies should consider other ethnic groups to further investigate the relationship between the C4 gene and SLE.
Literature
1.
go back to reference Javinani A, Ashraf-Ganjouei A, Aslani S, et al. Exploring the etiopathogenesis of systemic lupus erythematosus: a genetic perspective. Immunogenetics. 2019;71:283–97.CrossRef Javinani A, Ashraf-Ganjouei A, Aslani S, et al. Exploring the etiopathogenesis of systemic lupus erythematosus: a genetic perspective. Immunogenetics. 2019;71:283–97.CrossRef
2.
go back to reference Dammacco R. Systemic lupus erythematosus and ocular involvement: an overview. Clin Exp Med. 2018;18(2):135–49.CrossRef Dammacco R. Systemic lupus erythematosus and ocular involvement: an overview. Clin Exp Med. 2018;18(2):135–49.CrossRef
3.
go back to reference Chen L, Morris DL, Vyse TJ. Genetic advances in systemic lupus erythematosus: an update. Curr Opin Rheumatol. 2017;29(5):423–33.CrossRef Chen L, Morris DL, Vyse TJ. Genetic advances in systemic lupus erythematosus: an update. Curr Opin Rheumatol. 2017;29(5):423–33.CrossRef
4.
go back to reference Teruel M, Alarcon-Riquelme ME. The genetic basis of systemic lupus erythematosus: what are the risk factors and what have we learned. J Autoimmun. 2016;74:161–75.CrossRef Teruel M, Alarcon-Riquelme ME. The genetic basis of systemic lupus erythematosus: what are the risk factors and what have we learned. J Autoimmun. 2016;74:161–75.CrossRef
5.
go back to reference Machado-Contreras JR, Muñoz-Valle JF, Cruz A, et al. Distribution of PTPN22 polymorphisms in SLE from western Mexico: correlation with mRNA expression and disease activity. Clin Exp Med. 2016;16(3):399–406.CrossRef Machado-Contreras JR, Muñoz-Valle JF, Cruz A, et al. Distribution of PTPN22 polymorphisms in SLE from western Mexico: correlation with mRNA expression and disease activity. Clin Exp Med. 2016;16(3):399–406.CrossRef
6.
go back to reference Palafox-Sánchez CA, Oregon-Romero E, Salazar-Camarena DC, et al. Association of interleukin-10 promoter haplotypes with disease susceptibility and IL-10 levels in Mexican patients with systemic lupus erythematosus. Clin Exp Med. 2015;15(4):439–46.CrossRef Palafox-Sánchez CA, Oregon-Romero E, Salazar-Camarena DC, et al. Association of interleukin-10 promoter haplotypes with disease susceptibility and IL-10 levels in Mexican patients with systemic lupus erythematosus. Clin Exp Med. 2015;15(4):439–46.CrossRef
7.
go back to reference Bomba L, Walter K, Soranzo N. The impact of rare and low-frequency genetic variants in common disease. Genome Biol. 2017;18(1):77.CrossRef Bomba L, Walter K, Soranzo N. The impact of rare and low-frequency genetic variants in common disease. Genome Biol. 2017;18(1):77.CrossRef
8.
go back to reference Macedo AC, Isaac L. Systemic lupus erythematosus and deficiencies of early components of the complement classical pathway. Front Immunol. 2016;7:55.CrossRef Macedo AC, Isaac L. Systemic lupus erythematosus and deficiencies of early components of the complement classical pathway. Front Immunol. 2016;7:55.CrossRef
9.
go back to reference Chen M, Daha MR, Kallenberg CG. The complement system in systemic autoimmune disease. J Autoimmun. 2010;34(3):J276–286.CrossRef Chen M, Daha MR, Kallenberg CG. The complement system in systemic autoimmune disease. J Autoimmun. 2010;34(3):J276–286.CrossRef
10.
go back to reference Son M, Diamond B, Santiago-Schwarz F. Fundamental role of C1q in autoimmunity and inflammation. Immunol Res. 2015;63(1–3):101–6.CrossRef Son M, Diamond B, Santiago-Schwarz F. Fundamental role of C1q in autoimmunity and inflammation. Immunol Res. 2015;63(1–3):101–6.CrossRef
11.
go back to reference Sandhu V, Quan M. SLE and serum complement: causative, concomitant or coincidental? The Open Rheumatol J. 2017;11:113–22.CrossRef Sandhu V, Quan M. SLE and serum complement: causative, concomitant or coincidental? The Open Rheumatol J. 2017;11:113–22.CrossRef
12.
go back to reference Mortensen S, Kidmose RT, Petersen SV, et al. Structural basis for the function of complement component C4 within the classical and lectin pathways of complement. J Immunol. 2015;194(11):5488–96.CrossRef Mortensen S, Kidmose RT, Petersen SV, et al. Structural basis for the function of complement component C4 within the classical and lectin pathways of complement. J Immunol. 2015;194(11):5488–96.CrossRef
13.
go back to reference Juptner M, Flachsbart F, Caliebe A, et al. Low copy numbers of complement C4 and homozygous deficiency of C4A may predispose to severe disease and earlier disease onset in patients with systemic lupus erythematosus. Lupus. 2018;27(4):600–9.CrossRef Juptner M, Flachsbart F, Caliebe A, et al. Low copy numbers of complement C4 and homozygous deficiency of C4A may predispose to severe disease and earlier disease onset in patients with systemic lupus erythematosus. Lupus. 2018;27(4):600–9.CrossRef
14.
go back to reference Tsang A, Sjoe MWP, Bultink IEM, Korswagen LA, et al. Comprehensive approach to study complement C4 in systemic lupus erythematosus: Gene polymorphisms, protein levels and functional activity. Mol Immunol. 2017;92:125–31.CrossRef Tsang A, Sjoe MWP, Bultink IEM, Korswagen LA, et al. Comprehensive approach to study complement C4 in systemic lupus erythematosus: Gene polymorphisms, protein levels and functional activity. Mol Immunol. 2017;92:125–31.CrossRef
15.
go back to reference Chen JY, Wu YL, Mok MY, et al. Effects of complement C4 gene copy number variations, size dichotomy, and C4A deficiency on genetic risk and clinical presentation of systemic lupus erythematosus in East Asian populations. Arthritis Rheumatol (Hoboken, NJ). 2016;68(6):1442–533.CrossRef Chen JY, Wu YL, Mok MY, et al. Effects of complement C4 gene copy number variations, size dichotomy, and C4A deficiency on genetic risk and clinical presentation of systemic lupus erythematosus in East Asian populations. Arthritis Rheumatol (Hoboken, NJ). 2016;68(6):1442–533.CrossRef
16.
go back to reference Kim JH, Jung SH, Bae JS, et al. Deletion variants of RABGAP1L, 10q21.3, and C4 are associated with the risk of systemic lupus erythematosus in Korean women. Arthritis Rheum. 2013;65(4):1055–63.CrossRef Kim JH, Jung SH, Bae JS, et al. Deletion variants of RABGAP1L, 10q21.3, and C4 are associated with the risk of systemic lupus erythematosus in Korean women. Arthritis Rheum. 2013;65(4):1055–63.CrossRef
17.
go back to reference Boteva L, Morris DL, Cortes-Hernandez J, et al. Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations. Am J Hum Genet. 2012;90(3):445–56.CrossRef Boteva L, Morris DL, Cortes-Hernandez J, et al. Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations. Am J Hum Genet. 2012;90(3):445–56.CrossRef
18.
go back to reference Lv Y, He S, Zhang Z, et al. Confirmation of C4 gene copy number variation and the association with systemic lupus erythematosus in Chinese Han population. Rheumatol Int. 2012;32(10):3047–53.CrossRef Lv Y, He S, Zhang Z, et al. Confirmation of C4 gene copy number variation and the association with systemic lupus erythematosus in Chinese Han population. Rheumatol Int. 2012;32(10):3047–53.CrossRef
19.
go back to reference Kamatani Y, Matsuda K, Ohishi T, et al. Identification of a significant association of a single nucleotide polymorphism in TNXB with systemic lupus erythematosus in a Japanese population. J Hum Genet. 2008;53(1):64–73.CrossRef Kamatani Y, Matsuda K, Ohishi T, et al. Identification of a significant association of a single nucleotide polymorphism in TNXB with systemic lupus erythematosus in a Japanese population. J Hum Genet. 2008;53(1):64–73.CrossRef
20.
go back to reference Yang Y, Chung EK, Wu YL, et al. Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Am J Hum Genet. 2007;80(6):1037–54.CrossRef Yang Y, Chung EK, Wu YL, et al. Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Am J Hum Genet. 2007;80(6):1037–54.CrossRef
21.
go back to reference Lo CK, Mertz D, Loeb M. Newcastle-Ottawa Scale: comparing reviewers' to authors' assessments. BMC Med Res Methodol. 2014;1(14):45.CrossRef Lo CK, Mertz D, Loeb M. Newcastle-Ottawa Scale: comparing reviewers' to authors' assessments. BMC Med Res Methodol. 2014;1(14):45.CrossRef
22.
go back to reference Yu CY, Belt KT, Giles CM, et al. Structural basis of the polymorphism of human complement components C4A and C4B: gene size, reactivity and antigenicity. The EMBO J. 1986;5(11):2873–81.CrossRef Yu CY, Belt KT, Giles CM, et al. Structural basis of the polymorphism of human complement components C4A and C4B: gene size, reactivity and antigenicity. The EMBO J. 1986;5(11):2873–81.CrossRef
23.
go back to reference Dodds AW, Ren XD, Willis AC, et al. The reaction mechanism of the internal thioester in the human complement component C4. Nature. 1996;379(6561):177–9.CrossRef Dodds AW, Ren XD, Willis AC, et al. The reaction mechanism of the internal thioester in the human complement component C4. Nature. 1996;379(6561):177–9.CrossRef
24.
go back to reference Carroll HA, Toumpakari Z, Johnson L, et al. The perceived feasibility of methods to reduce publication bias. PLoS ONE. 2017;12(10):e0186472.CrossRef Carroll HA, Toumpakari Z, Johnson L, et al. The perceived feasibility of methods to reduce publication bias. PLoS ONE. 2017;12(10):e0186472.CrossRef
Metadata
Title
Association between complement 4 copy number variation and systemic lupus erythematosus: a meta-analysis
Authors
Ziyan Wu
Shulan Zhang
Ping Li
Fengchun Zhang
Yongzhe Li
Publication date
01-11-2020
Publisher
Springer International Publishing
Published in
Clinical and Experimental Medicine / Issue 4/2020
Print ISSN: 1591-8890
Electronic ISSN: 1591-9528
DOI
https://doi.org/10.1007/s10238-020-00640-5

Other articles of this Issue 4/2020

Clinical and Experimental Medicine 4/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.